SBBP - Strongbridge Biopharma plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5150.1M
Enterprise Value 365.53M
Trailing P/E 6.37
Forward P/E 1-3.15
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.40
Price/Book (mrq)1.64
Enterprise Value/Revenue 33.23
Enterprise Value/EBITDA 6-0.88

Trading Information

Stock Price History

Beta (3Y Monthly) 0.21
52-Week Change 3-34.82%
S&P500 52-Week Change 33.36%
52 Week High 36.5200
52 Week Low 32.0700
50-Day Moving Average 32.6080
200-Day Moving Average 33.5124

Share Statistics

Avg Vol (3 month) 3196.91k
Avg Vol (10 day) 3405.77k
Shares Outstanding 554.19M
Float 28.27M
% Held by Insiders 110.29%
% Held by Institutions 167.10%
Shares Short (Aug 15, 2019) 41.13M
Short Ratio (Aug 15, 2019) 410.48
Short % of Float (Aug 15, 2019) 42.65%
Short % of Shares Outstanding (Aug 15, 2019) 42.08%
Shares Short (prior month Jul 15, 2019) 41.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 181.51%
Operating Margin (ttm)-397.62%

Management Effectiveness

Return on Assets (ttm)-34.60%
Return on Equity (ttm)73.52%

Income Statement

Revenue (ttm)20.28M
Revenue Per Share (ttm)0.40
Quarterly Revenue Growth (yoy)41.50%
Gross Profit (ttm)14.04M
EBITDA -74.52M
Net Income Avi to Common (ttm)36.82M
Diluted EPS (ttm)0.4350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)86.17M
Total Cash Per Share (mrq)1.59
Total Debt (mrq)1.6M
Total Debt/Equity (mrq)1.76
Current Ratio (mrq)5.31
Book Value Per Share (mrq)1.68

Cash Flow Statement

Operating Cash Flow (ttm)-88.44M
Levered Free Cash Flow (ttm)-39.73M